CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,689,359 | -29.9% | 1,809,261 | -12.4% | 0.01% | -35.7% |
| Q1 2023 | $10,971,395 | +68304.5% | 2,066,176 | -19.1% | 0.01% | -39.1% |
| Q4 2022 | $16,039 | -100.0% | 2,553,878 | -22.4% | 0.02% | -55.8% |
| Q3 2022 | $34,719,000 | +137.8% | 3,290,898 | +22.4% | 0.05% | +160.0% |
| Q2 2022 | $14,603,000 | -40.7% | 2,689,227 | +0.2% | 0.02% | -28.6% |
| Q1 2022 | $24,644,000 | -14.8% | 2,684,548 | +40.1% | 0.03% | -3.4% |
| Q4 2021 | $28,919,000 | -38.3% | 1,916,431 | -2.5% | 0.03% | -44.2% |
| Q3 2021 | $46,898,000 | – | 1,964,707 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
| PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
| Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
| Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
| Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
| Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
| Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |